Related references
Note: Only part of the references are listed.Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease
Bhupinder Kumar et al.
CURRENT MEDICINAL CHEMISTRY (2022)
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure-Activity Relationships
Ravi Ranjan Kumar et al.
CHEMMEDCHEM (2021)
Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review
Karanvir Singh et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Revitalizing monoamine oxidase inhibitors: a call for action
P. Ken Gillman et al.
CNS SPECTRUMS (2020)
Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease
Silvia Chaves et al.
MOLECULES (2020)
Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT1A and D2 receptor affinity and serotonin transporter inhibition
Martyna Z. Wrobel et al.
BIOORGANIC CHEMISTRY (2020)
Experimental and DFT studies on the molecular structure, spectroscopic properties, and molecular docking of 4-phenylpiperazine-1-ium dihydrogen phosphate
Olfa Noureddine et al.
JOURNAL OF MOLECULAR STRUCTURE (2020)
Recent advancements in the development of heterocyclic anti-inflammatory agents
Sahil Sharma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, Synthesis and Evaluation ofO-Pentyne Substituted Diphenylpyrimidines as Monoamine Oxidase and Acetylcholinesterase Inhibitors
Vijay Kumar et al.
CHEMISTRYSELECT (2020)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability
Anna Czopek et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Design, synthesis and molecular modelling of new bulky Fananserin derivatives with altered pharmacological profile as potential antidepressants
Przemyslaw Zareba et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase
Bhupinder Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis of N-(phenoxyalkyl)-, N-{2-[2-(phenoxy)ethoxy]ethyl}- or N-(phenoxyacetyl)piperazine Derivatives and Their Activity Within the Central Nervous System
Katarzyna Panczyk et al.
CHEMISTRYSELECT (2019)
4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
Bhupinder Kumar et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Characteristics of metabolic stability and the cell permeability of 2-pyrimidinyl-piperazinyl-alkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione with antidepressant- and anxiolytic-like activities
Agnieszka Zagorska et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives
Mina Saeedi et al.
CHEMISTRY & BIODIVERSITY (2019)
Association of age with risk of major depression among patients with chronic kidney disease over midlife: a nationwide cohort study in Taiwan
Shih-Feng Chen et al.
INTERNATIONAL PSYCHOGERIATRICS (2019)
Off-label uses of drugs for depression
Sigrid S. Skanland et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Profiling of LINS01 compounds at human dopamine D2 and D3 receptors
Michelle F. Correa et al.
JOURNAL OF CHEMICAL SCIENCES (2019)
A Review of Novel Antidepressants: A Guide for Clinicians
Amber E. Faquih et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2019)
Talipexole variations as novel bitopic dopamine D2 and D3 receptor ligands
Lars Stank et al.
MEDCHEMCOMM (2019)
Synthesis and activity of di- or trisubstituted N-(phenoxyalkyl)- or N-{2-[2-(phenoxy)ethoxy]ethyl}piperazine derivatives on the central nervous system
Katarzyna Panczyk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Design, synthesis, evaluation, and molecular docking of ursolic acid derivatives containing a nitrogen heterocycle as anti-inflammatory agents
Zhi-Yu Wei et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors
Bhupinder Kumar et al.
BIOORGANIC CHEMISTRY (2018)
Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents
Bhupinder Kumar et al.
CHEMMEDCHEM (2018)
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor
Fabio Del Bello et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands
Andrea Rague et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment
Yi-Ming Shao et al.
PLOS ONE (2018)
The burden of Parkinson's disease: a worldwide perspective
Walter A. Rocca
LANCET NEUROLOGY (2018)
A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Bhupinder Kumar et al.
CURRENT DRUG TARGETS (2017)
The computer-aided discovery of novel family of the 5-HT6 serotonin receptor ligands among derivatives of 4-benzyl-1,3,5-triazine
Dorota Lazewska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors
Betul Kaya et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Recent Advances in Piperazine Synthesis
Kristen E. Gettys et al.
SYNTHESIS-STUTTGART (2017)
Design, synthesis and pharmacological evaluation of some novel derivatives of 1-{[3-(furan-2-yl)-5phenyl-4,5-dihydro-1,2-oxazol-4-yl]methyl}-4methyl piperazine
Jagdish Kumar et al.
ARABIAN JOURNAL OF CHEMISTRY (2017)
Synthesis,Molecular Properties Estimations,and Dual Dopamine D2 and D3Receptor Activities of Benzothiazole-Based-Ligands
Moritz Schuebler et al.
FRONTIERS IN CHEMISTRY (2017)
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Marcela Cruz-Haces et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Synthesis of new piperazine compounds and investigation of their anticholinesterase effects
Yusuf Ozkay
CUKUROVA MEDICAL JOURNAL (2017)
Synthesis, docking study and neuroprotective effects of some novel pyrano[3,2-c]chromene derivatives bearing morpholine/phenylpiperazine moiety
Bilqees Sameem et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation
Anna Wieckowska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Piperazine derivatives for therapeutic use: a patent review (2010-present)
Anuj K. Rathi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Antidepressant-like activity of aroxyalkyl derivatives of 2-methoxyphenylpiperazine and evidence for the involvement of serotonin receptor subtypes in their mechanism of action
Monika Kubacka et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2016)
Recent developments on the structure-activity relationship studies of MAO inhibitors and their role in different neurological disorders
Bhupinder Kumar et al.
RSC ADVANCES (2016)
Piperazine derivatives as iron chelators: a potential application in neurobiology
S. Abdelsayed et al.
BIOMETALS (2015)
Synthesis and Evaluation of Antidepressant-like Activity of Some 4-Substituted 1-(2-methoxyphenyl) Piperazine Derivatives
Anna M. Waszkielewicz et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine
Stuart A. Montgomery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Structural Modifications of Neuroprotective Anti-Parkinsonian (-)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Efficacy of the Parent Molecule
Gyan Modi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Characterization of [3H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand
Claudia Rangel-Barajas et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits
Ümide Demir Özkay et al.
Pharmacological Reports (2014)
2013 Alzheimer's disease facts and figures Alzheimer's Association
William Thies et al.
ALZHEIMERS & DEMENTIA (2013)
Update on 1-benzylpiperazine (BZP) party pills
Marcia Sa Monteiro et al.
ARCHIVES OF TOXICOLOGY (2013)
Synthesis, molecular modeling and evaluation of novel N′-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and Aβ aggregation
Eda Ozturan Ozer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection
Manjinder Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors
Leyla Yurttas et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer's Disease Based on the Fusion of Donepezil and Ebselen
Zonghua Luo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors
Irene Bolea et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Binding Modes of Chain Arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 Receptors
Anna Bielenica et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
Synthesis, docking and acetylcholinesterase inhibitory assessment of 2-(2-(4-Benzylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects
Ahmad Mohammadi-Farani et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors
Ming-xin Dong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors
Bo Song et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Piperazine compounds as drugs of abuse
M. D. Arbo et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Phenylpiperazine derivatives: a patent review (2006-present)
Rodolfo do Couto Maia et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Structure-Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl) piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization
Mark Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Synthesis and Biological Evaluation of Thiophene Derivatives as Acetylcholinesterase Inhibitors
Mohamed M. Ismail et al.
MOLECULES (2012)
Synthesis of New Indole Derivatives Structurally Related to Donepezil and Their Biological Evaluation as Acetylcholinesterase Inhibitors
Mohamed M. Ismail et al.
MOLECULES (2012)
Synthesis, Docking Studies and Biological Evaluation of Benzo[b]thiophen-2-yl-3-(4-arylpiperazin-1-yl)-propan-1-one Derivatives on 5-HT1A Serotonin Receptors
Hernan Pessoa-Mahana et al.
MOLECULES (2012)
Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal
Jagat R. Kanwar et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Design and synthesis of novel piperazine unit condensed 2,6-diarylpiperidin-4-one derivatives as antituberculosis and antimicrobial agents
Mannangatty Rani et al.
MEDICINAL CHEMISTRY RESEARCH (2012)
Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation
Tarek Mohamed et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Potent and selective adenosine A2A receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones
Joel M. Harris et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors
Alexandra Gaspar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships
Adela Mendoza et al.
EXPERIMENTAL PARASITOLOGY (2011)
Design and Synthesis of Novel Arylpiperazine Derivatives Containing the Imidazole Core Targeting 5-HT2A Receptor and 5-HT Transporter
Hee Jeong Seo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Benny Bang-Andersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Antidepressant-like activity of the phenylpiperazine pyrrolidin-2-one derivatives in mice
Jacek Sapa et al.
PHARMACOLOGICAL REPORTS (2011)
Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant
Jong Yup Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and antidepressant activity of optical isomers of 2-(4-benzylpiperazin-1-yl)-1-(5-chloro-6-methoxynaphthalen-2-yl) propan-1-ol (SIPI5056)
Zhijie Weng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant
Suk Youn Kang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity
Anna Czopek et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
An in vivo pharmacological evaluation of pardoprunox (SLV308) - A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease
C. A. Jones et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
The partial dopamine agonist pardoprunox (SLV308) administered in combination with L-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets
K. Tayarani-Binazir et al.
EXPERIMENTAL NEUROLOGY (2010)
Development of (S)-N6-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6, 7-tetrahydrobenzo[d]-thiazole-2,6-diamine and Its Analogue as a D3 Receptor Preferring Agonist: Potent in Vivo Activity in Parkinson's Disease Animal Models
Balaram Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Novel D3 Dopamine Receptor-Preferring Agonist D-264: Evidence of Neuroprotective Property in Parkinson's Disease Animal Models Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine and Lactacystin
Chao Li et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Synthesis of Benzofuran Derivatives via Rearrangement and Their Inhibitory Activity on Acetylcholinesterase
Xiang Zhou et al.
MOLECULES (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study
Osvaldo P. Almeida et al.
PLOS ONE (2010)
Synthesis and evaluation of 1-(quinoliloxypropyl)-4-aryl piperazines for atypical antipsychotic effect
Alka Bali et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis and preliminary pharmacological evaluation of imidazo[2,1-f]purine-2,4-dione derivatives
Agnieszka Zagorska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Site-Activated Multifunctional Chelator with Acetylcholinesterase and Neuroprotective-Neurorestorative Moieties for Alzheimer's Therapy
Hailin Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Dopamine D2, D3, and D4 Selective Phenylpiperazines as Molecular Probes To Explore the Origins of Subtype Specific Receptor Binding
Katharina Ehrlich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
N-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with Functionalized Linking Chains as High Affinity and Enantioselective D3 Receptor Antagonists
Amy Hauck Newman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers
Elisabetta Martini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues
Xiang Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands
Maria A. Siracusa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: Identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity
Swati Biswas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Vesicular monoamine transporter substrate/inhibitor activity of MPTP/MPP+ derivatives:: A structure-activity study
D. Shyamali Wimalasena et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
N-[ω-[4-(2-methoxyphenyl)-1-piperazinyl]alkyl]-2-quinolinamines as high-affinity fluorescent 5-HT1A receptor ligands
Enza Lacivita et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
Jyothi K. Mallajosyula et al.
PLOS ONE (2008)
Benzylpiperazine: a drug of abuse?
Alice C. Johnstone et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation
C. S. Ananda Kumar et al.
MEDICINAL CHEMISTRY RESEARCH (2007)
3H-[1,2,4]-Triazolo[5,1-i]purin-5-amine derivatives as adenosine A2A antagonists
Lisa S. Silverman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D3 receptor partial agonist in animal models of cocaine abuse
Istvan Gyertyan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Potent, selective, and orally active adenosine A2A receptor antagonists:: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
Bernard R. Neustadt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human β-secretase inhibitors.: Design, synthesis, and enzymatic BACE-1 and cell assays
Cedrik Garino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression
Oren M. Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands.: Development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties
A Cappelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and biological evaluation of 2-(4-fluorophenoxy)-2-phenyl-ethyl piperazines as serotonin-selective reuptake inhibitors with a potentially improved adverse reaction profile
JM Dorsey et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Indolebutylamines as selective 5-HT1A agonists
T Heinrich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents:: A combined neurochemical and behavioral analysis
MJ Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D3 receptor Ligands
M Leopoldo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Mono N-arylation of piperazine(III):: metal-catalyzed N-arylation and its application to the novel preparations of the antifungal posaconazole and its advanced intermediate
M Hepperle et al.
TETRAHEDRON LETTERS (2002)
A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments:: Binding activity at D2 and D3 receptors
AK Dutta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Arylpiperazine derivatives acting at 5-HT1A receptors
ML López-Rodríguez et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype
MJ Robarge et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Excess mortality in bipolar and unipolar disorder in Sweden
U Ösby et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Molecular simplification of 1,4-diazabicyclo[4.3,0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity
D Manetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Design, synthesis, and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents
D Manetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
